Meet Our Board

Jason Gorevic

Chief Executive Officer and Director

Mr. Gorevic is chief executive officer of Teladoc Health and has been a member of the board of directors since June 2009.

Under Mr. Gorevic’s visionary leadership, Teladoc Health has continued to set the bar in the virtual delivery of care, achieving unprecedented milestones and defining the market. He is responsible for driving the growth and innovation strategies that have led to transformative results for Teladoc Health’s members, clients, partners, employees, and shareholders. He took the company public in 2015, and has grown it to more than $200 million in revenue in 2017. Under his leadership the company has established a proven track record of driving healthcare transformation by executing on the corporate strategic vision, delivering award-winning innovation, and effectively integrating each corporate acquisition.

Prior to joining Teladoc Health, Mr. Gorevic served in various management roles at WellPoint, Inc. (now Anthem, Inc.), including president of Empire BlueCross BlueShield and senior vice president and chief sales and product officer.

From 2002 to 2005, Mr. Gorevic was a member of Empire BlueCross BlueShield’s leadership team, as chief sales and marketing officer. From July 2000 to December 2001, Mr. Gorevic served as chief executive officer of Gemfinity, an electronic marketplace and purchasing aggregator that he founded. From July 1999 to July 2000, he served as general manager of business messaging at, Inc., a provider of internet messaging services, and from April 1998 to June 1999, he served as’s vice president of operations.

Mr. Gorevic is a nationally recognized thought leader and trailblazer in virtual healthcare delivery. Prior to joining Teladoc Health, he held various executive leadership roles at WellPoint, Inc. (now Anthem, Inc.), Empire BlueCross BlueShield, Oxford Health,, and Gemfinity.

He is a member of the board of directors of the New York Road Runners and serves on its youth and community service committee.

David B. Snow, Jr.

Non-executive chairman of the board

Mr. Snow became a member of our board of directors in February 2014 and later was named chairman of our board in December 2014.

Since February 2014, Mr. Snow has served as chairman and chief executive officer of Cedar Gate Technologies, Inc., a provider of analytic and information technology services to doctor and hospital organizations entering risk-based reimbursement arrangements with insurers. Until April 2012, Mr. Snow was chairman and chief executive officer of Medco Health Solutions, Inc., a leading pharmacy benefit manager. His current board service includes CareCentrix (since 2014) and Pitney Bowes, Inc. (since 2006). He formerly served as a director of Medco Health Solutions, Inc.

In addition to his experience as the chief executive officer of a public company, Mr. Snow has a strong background in operations, having served in leadership positions at several companies including WellChoice (Empire Blue Cross Blue Shield) and Oxford Health Plans. Mr. Snow earned a Bachelor of Science in economics from Bates College and a master’s degree in healthcare administration from Duke University.

Helen Darling


Ms. Darling became a member of our board of directors in June 2016.

She is currently a strategic advisor in health benefits and policy in Washington, D.C. She previously served as interim president and CEO of the National Quality Forum (NQF), as well as a past president and chief executive officer of the National Business Group on Health (NBGH). Ms. Darling serves on the Committee on Performance Measurement of the National Committee for Quality Assurance (NCQA) and the Medical Advisory Panel of the Blue Cross Blue Shield Association’s Center for Clinical Effectiveness. Previously in her career, she directed the purchasing of health and disability benefits at Xerox Corporation for 55,000 U.S. employees. She also served as a principal at William W. Mercer and a practice leader at Watson Wyatt.

Ms. Darling was named one of the “60 Most Powerful People in Healthcare” by Becker’s Hospital Review in 2016 and named one of Modern Healthcare’s “100 Most Influential People in Healthcare” from 2003 to 2007 and 2010 to 2013. Her current board service includes the Advisory Board for the Peter G. Peterson Foundation and the Board of the Reagan-Udall Foundation for the FDA. She directed studies at the Institute of Medicine and was LA on health policy for former U.S. Sen. David Durenberger, Senate Finance Committee. Ms. Darling holds a master’s degree in demography and sociology and a Bachelor of Science in history and English, cum laude, from the University of Memphis.

William H. Frist, M.D.


U.S. Sen. William Frist became a member of our board of directors in September 2014. Since 2007, Sen. Frist has served as a partner in Cressey & Company, a private investment firm focused exclusively on growing emerging health care businesses. He served as U.S. Senator for Tennessee from 1995 to 2007 and was majority leader of the Senate from 2003 to 2007, participating in the debate and development of major public policy issues and health legislation. Prior to the Senate, Sen. Frist spent 20 years in clinical medicine, completing surgical training at Harvard’s Massachusetts General Hospital and at Stanford; he subsequently founded the Vanderbilt Multi-Organ Transplant Center. Sen. Frist serves as an adjunct professor of cardiac surgery at Vanderbilt University and clinical professor of surgery at Meharry Medical College. Sen. Frist currently serves as a member of the board of the publicly held companies Select Medical and AECOM. In addition, he serves as a board member for several of Cressey & Company’s privately held portfolio companies. He previously served as a director of URS Corporation from November 2009 to 2014, and on the board of Third National Bank from 1990 to 1994.

Sen. Frist serves on the boards of several other organizations, including the Center for Strategic and International Studies, Partnership for a Healthier America, Hope Through Healing Hands, the Kaiser Family Foundation, the Robert Wood Johnson Foundation, the Nashville Health Care Council and the Harvard Medical School Board of Fellows.

He is a senior fellow at the Bipartisan Policy Center, where he is co-leader of the Health Project. Sen. Frist earned a Bachelor of Arts from Princeton University and an M.D. from Harvard Medical School.

Michael Goldstein


Mr. Goldstein became a member of our board of directors in February 2015.

Mr. Goldstein is the retired chairman and chief executive officer of Toys “R” Us, Inc. He joined Toys “R” Us in 1983 as chief financial officer and served in various executive-level positions in the course of his 18-year tenure there.

Since 2015, Mr. Goldstein has served as director and member of the audit committee and corporate strategy committee of BioScrip, Inc. He was formerly the lead director for Medco Health Solutions, Inc., one of the largest pharmacy benefit managers and mail order pharmacy operators in the United States, which was acquired by Express Scripts Holding Company. He is also a former partner at Ernst & Young LLP and is a director of numerous private companies and not-for-profit charitable organizations. He is a certified public accountant and graduated magna cum laude from Queens College with a Bachelor of Science in economics.

Brian McAndrews


Mr. McAndrews became a member of our board of directors in September 2017.

The former chief executive officer, president, and chairman of Pandora Media, he has a depth of knowledge in data, analytics, and artificial intelligence (AI). Mr. McAndrews currently sits on the board of Amplero, a recognized leader in leveraging AI marketing to maximize customer lifetime value and loyalty, and also served as president and CEO of aQuantive, Inc., a top 10 global digital marketing services and adtech company that was acquired by Microsoft.

Mr. McAndrews has spent a significant portion of his career driving growth and innovation for leading advertising and content companies. For nearly a decade he held positions of increasing responsibility at ABC, Inc., leaving as executive vice president and general manager of ABC Sports.

He was named one of “The Power 100” by Billboard Magazine in 2016 and 2015, as well as one of the 30 most influential executives in the advertising, marketing, and media world by Adweek in 2008. Mr. McAndrews is chairman of the technology and innovation committees of The New York Times, chairman of the board of Grubhub, and also sits on the boards of The Wine Group and the United Way of King County. He holds an MBA from Stanford Graduate School of Business and a Bachelor of Arts from Harvard College.

Thomas G. McKinley


Mr. McKinley became a member of our board of directors in November 2009.

Mr. McKinley, who has more than 35 years of investment experience, is a general partner and the West Coast representative for Cardinal Partners, a venture capital firm focused exclusively on healthcare investing. Prior to joining Cardinal, Mr. McKinley was the co-founder and co-managing partner of Partech International. Mr. McKinley currently serves on the board of directors of lifeIMAGE, a cloud-based medical imaging sharing platform for hospitals, physicians, and patients.

In addition, Mr. McKinley is the founding chief executive officer and director of Cardinal Analytx, a software startup spun out of Stanford University that was created to identify and target high-cost patients for early medical interventions. Mr. McKinley earned Bachelor of Arts in economics from Harvard University, a Master of Science in accounting from New York University and a Master of Business Administration from the Stanford Graduate School of Business.

Arneek Multani


Mr. Multani became a member of our board of directors in 2008.

Mr. Multani is a managing director of Trident Capital, where he leads the firm’s healthcare IT practice, and is a co-founder and managing director of TC Growth, a growth-equity firm spun out of Trident Capital in 2015. Prior to joining Trident in 2002, Mr. Multani was an associate at McCown De Leeuw, a private equity firm specializing in leveraged buyouts, where he focused on investing in the health and fitness industries.

He started his career as an analyst at Morgan Stanley in the media and telecommunications area of the mergers and acquisitions group. Mr. Multani currently sits on the board of directors of Imagine Health, ArroHealth, and HealthMEDX. His past directorships and observer-ships include Acclaris, Resolution Health, and Profex. Mr. Multani earned a Bachelor of Science in economics from Wharton School and a Bachelor of Applied Science in systems engineering from the Moore School of Engineering at the University of Pennsylvania. He earned his Master of Business Administration from the Stanford Graduate School of Business.

Kenneth H. Paulus


Mr. Paulus became a member of our board of directors in February 2017.

From 2009 to 2014, Mr. Paulus was President and CEO of Allina Health, one of the nation’s largest not-for-profit integrated delivery systems consisting of nearly 1,500 employed physicians, 13 acute care hospitals, a freestanding emergency department, and more than 100 ambulatory care clinics. Prior to his appointment as CEO, he served as President and Chief Operating Officer of Allina Health. Before joining Allina, Mr. Paulus was the President and CEO of Atrius Health, one of the largest integrated physician organizations in New England and a teaching and research affiliate of Harvard Medical School. He also served as the Chief Operating Officer of Boston-based Partners Community HealthCare, a teaching affiliate of Harvard Medical School that includes Massachusetts General Hospital and Brigham and Women’s Hospital.

Mr. Paulus is an executive advisor at Water Street Healthcare Partners, a private investment firm, and currently serves on the board of Healthgrades. Mr. Paulus received his Master of Healthcare Administration from the University of Minnesota, and a Bachelor of Arts in biology from Augustana College.

David L. Shedlarz


Mr. Shedlarz became a member of our board in September 2016.

He is the former vice chairman, executive vice president, and chief financial officer of Pfizer, Inc., having had worldwide responsibility for the company’s former Medical Technology Group. During his 31-year tenure at Pfizer, Mr. Shedlarz played a key role in shaping the strategic direction that drove the company’s impressive growth and helped establish it as an industry leader and innovator. Among his senior leadership roles were that of executive vice president beginning in 1999, and then vice chairman in 2005, serving until his retirement in 2007.

In addition to the Teladoc Health board, Mr. Shedlarz also sits on the boards of The Hershey Company, Pitney Bowes, Inc., and the Teachers Insurance and Annuity Association of America. He holds a Master of Business Administration in finance and accounting from New York University's Leonard N. Stern School of Business, and a Bachelor of Science in economics and mathematics from Michigan State University–Oakland.

Mark D. Smith, MD, MBA


Dr. Mark Smith became a member of our board of directors in 2018.

He is a professor of clinical medicine at the University of California at San Francisco as well as a visiting professor at the School of Public Health at UC Berkeley. He is a board-certified internist and maintains a clinical practice in HIV care at San Francisco General Hospital. A nationally recognized care delivery and health policy expert, Dr. Smith is current co-chair of the Guiding Committee of the Health Care Payment Learning & Action Network, a public-private partnership launched by the U.S. Department of Health and Human Services. The group promotes the transition to value-based payment to improve care quality while lowering costs.

From 1996 through 2013 he served as the founding president and CEO of the California Health Care Foundation, an independently endowed philanthropy that works to improve healthcare access and quality for Californians. He helped build the foundation into a recognized leader in delivery system innovation, public reporting of care quality, and applications of new technology in healthcare.

Dr. Smith was formerly executive vice-president of the Henry J. Kaiser Family Foundation. He was elected to the Institute of Medicine and chaired the IOM’s Committee on The Learning Health Care System in America. He serves on the boards of the Institute for Healthcare Improvement and the Commonwealth Fund and is on the editorial board of Health Affairs. He received his BA from Harvard College, his MD from the University of North Carolina at Chapel Hill, and his MBA from the Wharton School at the University of Pennsylvania.

Want to learn more about our leadership?

Meet Leadership Team